Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
PharmacokineticsInhibition EnzymeDrug Interaction Potentiation
Interventions
DRUG

intravenous infusion of 2 mg trospium chloride

intravenous infusion of 2 mg trospium chloride in 20 ml saline within 60 min and 240 ml tap water p.o

DRUG

oral administration of 30 mg trospium chloride

oral administration of 30 mg trospium chloride with 240 ml tap water

DRUG

oral administration of 300 mg ranitidine

oral administration of 300 mg ranitidine with 240 ml tap water

DRUG

oral administration of 500 mg clarithromycin

oral administration of 500 mg clarithromycin with 240 ml tap water

All Listed Sponsors
lead

Dr. R. Pfleger Chemische Fabrik GmbH

INDUSTRY

NCT03011463 - Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1 | Biotech Hunter | Biotech Hunter